Emerging Clinical Evidence for the Use of ENHERTU in HER2+ Breast Cancer ~ 7/29/26

Jul 11
1 min read

Join this wonderful discussion!

Wednesday, July 29th

6:00 PM Eastern

Capital Grille

250 Boylston Street, Chestnut Hill, MA 02467

Recent Posts

See All

Advocate for Change Join the Massachusetts Biomarker Testing Coalition Lobby Day, NEXT WEEK May 13th

NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress

Management of high-risk non-melanoma skin cancers (NMSC)

Dear BONS Membes, I’d like to invite you to join a Dana-Farber–anchored, multidisciplinary CME activity focused on the management of high-risk non-melanoma skin cancers (NMSC)—including BCC, cSCC, and

Comments